The FBI on Economic Espionage
The Justice Insiders Podcast: Varsity Blues Reversals Turn DOJ Red
[Podcast] Cyber Spotlight: Wiley Tackles White House’s National Cybersecurity Strategy and Other Developments
No Password Required: An FBI Special Agent's Journey from Submarines to Anti-Corruption to Cybersecurity
The New Cold War: Risk, Sanctions, Compliance Episode 23: "Former FBI Acting Director Andrew McCabe”
The Latest from the DOJ Antitrust Division
The Presumption of Innocence Podcast: Episode 7 - Investigative Insights: A Conversation with a Former FBI Agent
DE Under 3: OFCCP AAP Verification Portal 'Rules of Behavior', Vaccination Injunction Updates, & Recent Job Scam Alerts
Cybersecurity: Headlines, Best Practices and Its Evolving Role
Digging Deeper, Episode 1: The Con Queen of Hollywood
Devil in the Details: Gilbert King on Truth and Transparency in the Judicial Process
Compliance Perspectives: The FBI on Why and How to Work with the Office of the Private Sector
This Week in FCPA-Episode 54, the Rubber Match Edition
Clinical Laboratory and CEO To Pay Over $13 Million to Settle False Claims Act Allegations - A New Jersey-based laboratory, RDx Bioscience Inc. (RDX), and its owner and CEO, Eric Leykin, agreed to pay $10,315,023 to the US...more
Similar to other types of healthcare entities, clinical laboratories have been facing enhanced scrutiny from federal authorities over the past couple of years. While this is due in part to fraud concerns related to COVID-19...more
Clinical laboratories have come under increased scrutiny in the past few years, especially those that deal with COVID-19 testing or drug testing. These federal investigations can be surprising and confusing for lab...more
In many ways, the COVID-19 pandemic increased the business opportunities available to clinical labs, including molecular and respiratory labs. As the nation—and the world—struggled to develop adequate testing infrastructure,...more